Azbil BioVigilant (ABV) Announces Partnership with University of Tennessee (UT) Pharmacy College

  Azbil BioVigilant (ABV) Announces Partnership with University of Tennessee
  (UT) Pharmacy College

  UT to Implement ABV’s Rapid Microbial Monitoring in New Aseptic Processing
                                     Area

Business Wire

TUCSON, Ariz. -- April 04, 2013

Azbil BioVigilant, Inc. (www.biovigilant.com), inventors of Instantaneous
Microbial Detection^™, announced today that the University of Tennessee (UT)
Pharmaceutical Sciences Department will utilize Azbil BioVigilant’s IMD-A®
300-series of rapid microbial monitoring systems in their state-of-the-art
aseptic filling facility.

The University of Tennessee is a leading institution in training individuals
in health sciences fields, and for the past 50 years has offered training in
aseptic processing. “Our new manufacturing facility, now under construction,
will provide an advanced training ground featuring cutting-edge technology
such as Azbil BioVigilant’s IMD-A system capable of real-time,
around-the-clock environmental monitoring,” said Professor Laura Thoma,
Director of UT’s Plough Center for Sterile Drug Delivery. “This laser-based
technique leverages naturally-occurring fluorescence to detect microbes, in
contrast to the culturing method in widespread use developed over a century
ago,” she added.

Aric Meares, CEO of Azbil BioVigilant, stated partnerships such as these
signify enabling steps for the industry. “The FDA continues to encourage the
adoption of new technologies that improve the sterile manufacturing process
and reduce the contamination risk to medications. The pharmaceutical industry
has made limited advancements in this area due, in part, to the lack of
published data. Our partnership with the University of Tennessee will help to
fill that information void,” he added.

The University aims to complete research on topics of wide interest to
pharmaceutical drug makers such as the relevance and impact of
paradigm-changing microbial detection sensitivity via intrinsic fluorescence,
the impact of rapid access to information warning of a change of state within
the drug-making environment, and the use of IMD-A systems as part of a larger
parametric (or real-time) product release process.

Azbil BioVigilant’s IMD-A 300 and IMD-A 350 systems can detect immediately the
presence of microbes in the pharmaceutical manufacturing process, and in doing
so, greatly accelerate the quality assurance processes for drug batch release.

About Azbil BioVigilant

With headquarters in Tucson, Arizona, Azbil BioVigilant invented instantaneous
microbial detection technology to address environmental monitoring needs in
the pharmaceutical, biotechnology, healthcare, and environmental applications.
Azbil BioVigilant’s IMD systems detect - instantaneously and in real-time -
particle count, size, and biological status. Unlike other rapid microbial
methods, Azbil BioVigilant’s optically-based systems require no staining, no
reagents, no waiting period, and little human intervention. The company holds
20 patents with an additional 37 applications pending. Azbil BioVigilant’s
parent company is Azbil Corporation of the azbil Group, part of the TOPIX
Mid400 traded on the Tokyo Stock Exchange. For more information, go to
www.biovigilant.com.

About UT Plough Center

Located on the Memphis campus of the University of Tennessee, the Plough
Center for Sterile Drug Delivery offers various hands-on training programs and
has manufacturing capabilities for sterile products. The Plough Center
contains a core processing facility designed for the preparation of sterile
dosage forms and instructional training in aseptic processing, sterilization
principles and production processes. Under the direction of the faculty and
staff of the College of Pharmacy, the facility and its associated laboratories
are utilized for formulation development, manufacturer of products for
clinical investigation and other applied research in parenteral technology
such as stability studies and development of lyophilization cycles. The Plough
Center also has experience in the aseptic processing radiolabeled products for
clinical investigations.

Trademark Notice

IMD-A®, BioVigilant®, the BioVigilant logo, and the term Instantaneous
Microbial Detection™ are the trademarks or registered trademarks of Azbil
BioVigilant, Inc. in the United States and/or other countries. Other names or
brands may be the property of others.

Contact:

Azbil BioVigilant
Mary Parsons, 520-292-2342
mparsons@biovigilant.com
 
Press spacebar to pause and continue. Press esc to stop.